Huntington Asset Advisors »

Halozyme Therapeutics shares owned by Huntington Asset Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Huntington Asset Advisors from 13F filings

Historical chart of Huntington Asset Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Huntington Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Huntington Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 2.4M 1.08

More positions owned by Huntington Asset Advisors

Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr Series Trust State Street Spd (SPAB)
Global X Fds Glb X Mlp Enrg I (MLPX)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Select Sector Spdr Tr State Street Uti (XLU)
Vanguard Specialized Funds Div App Etf (VIG)
Wisdomtree Tr Us Efficient Cor (NTSX)
Schwab Strategic Tr Us Reit Etf (SCHH)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Spdr Series Trust State Street Spd (SPHY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Global X Fds Us Pfd Etf (PFFD)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Huntington Asset Advisors

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation
Ameriprise Financial
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
FMR

View all funds holding Halozyme Therapeutics